Patent · US Active

Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies

US9428583B2 · kind B2 · utility

1Cited by
23References
52Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 5, 2011
Grant dateAug 30, 2016
Priority date
Expiry dateMay 5, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to antibodies targeting LRP6 and compositions and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.